In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Semler Scientific Inc (NASDAQ: SMLR) was $25.73 for the day, down -5.92% from the previous closing price of $27.35. In other words, the price has decreased by -$5.92 from its previous closing price. On the day, 0.93 million shares were traded. SMLR stock price reached its highest trading level at $27.65 during the session, while it also had its lowest trading level at $24.2601.
Ratios:
Our analysis of SMLR’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 29.82 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 34.00. For the most recent quarter (mrq), Quick Ratio is recorded 0.58 and its Current Ratio is at 0.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 08, 2025, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $101.
B. Riley Securities Downgraded its Buy to Neutral on November 02, 2022, whereas the target price for the stock was revised from $60 to $45.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 25 ’25 when Murphy-Chutorian Douglas sold 28,604 shares for $30.54 per share. The transaction valued at 873,566 led to the insider holds 31,396 shares of the business.
Douglas Murphy-Chutorian bought 60,000 shares of SMLR for $1,847,400 on Aug 25 ’25. On Dec 10 ’24, another insider, Murphy-Chutorian Douglas, who serves as the CEO of the company, sold 75,000 shares for $60.12 each. As a result, the insider received 4,508,683 and left with 65,083 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMLR now has a Market Capitalization of 389608672 and an Enterprise Value of 463721760. As of this moment, Semler’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.64 while its Price-to-Book (P/B) ratio in mrq is 0.92. Its current Enterprise Value per Revenue stands at 10.79 whereas that against EBITDA is 85.795.
Stock Price History:
The Beta on a monthly basis for SMLR is 1.33, which has changed by -0.39624727 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, SMLR has reached a high of $81.56, while it has fallen to a 52-week low of $21.84. The 50-Day Moving Average of the stock is -7.08%, while the 200-Day Moving Average is calculated to be -27.40%.
Shares Statistics:
SMLR traded an average of 1.02M shares per day over the past three months and 747190 shares per day over the past ten days. A total of 15.14M shares are outstanding, with a floating share count of 13.75M. Insiders hold about 9.20% of the company’s shares, while institutions hold 76.01% stake in the company. Shares short for SMLR as of 1761868800 were 2080752 with a Short Ratio of 2.04, compared to 1759190400 on 3143562. Therefore, it implies a Short% of Shares Outstanding of 2080752 and a Short% of Float of 15.560001000000002.
Earnings Estimates
. The current rating of Semler Scientific Inc (SMLR) is the result of assessments by 2 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.2, with high estimates of $0.03 and low estimates of -$0.44.
Analysts are recommending an EPS of between -$3.66 and -$3.66 for the fiscal current year, implying an average EPS of -$3.66. EPS for the following year is -$0.75, with 2.0 analysts recommending between $0.08 and -$1.58.
Revenue Estimates
For the next quarter, 3 analysts are estimating revenue of $6.78M. There is a high estimate of $8.55M for the next quarter, whereas the lowest estimate is $3.3M.
Based on 3 analysts’ estimates, the company’s revenue will be $27.1M in the next fiscal year. The high estimate is $34.72M and the low estimate is $14.18M.
